NeurAxon Inc. logo
Exited company

NeurAxon Inc.

Details
Region
Ontario
Industry sector
Biotechnology
Investment year
2007
Fund
Diversified Portfolio
Learn more
About the company

NeurAxon is a leader in discovering and developing next-generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating chronic pain and central nervous system neuronal sensitization.

Your privacy

BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.

To find out more, consult our Policy on confidentiality.